Artemis Medicare Services Limited has released the Monitoring Agency Report for the quarter ended September 30, 2024, detailing the utilization of proceeds from its Rs. 330 crore preferential issue of Compulsorily Convertible Debentures. The report indicates no deviations from the stated objectives for the raised funds. During the period, approximately Rs. 7.94 crore was utilized for general corporate purposes, with Rs. 322.06 crore remaining unutilized primarily intended for expansion. This stability reflects a positive outlook for managing resources; however, the underutilization of funds for strategic expansion may raise some concerns among investors regarding growth momentum.